Global Cord Blood (CO) Competitors $1.45 0.00 (0.00%) As of 07/7/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock CO vs. CORBF, MRAI, REPL, VIR, MPLN, SION, GYRE, OMI, CBLL, and NUTXShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Global Cord Blood (CORBF), Marpai (MRAI), Replimune Group (REPL), Vir Biotechnology (VIR), MultiPlan (MPLN), Sionna Therapeutics (SION), Gyre Therapeutics (GYRE), Owens & Minor (OMI), CeriBell (CBLL), and Nutex Health (NUTX). Global Cord Blood vs. Its Competitors Global Cord Blood Marpai Replimune Group Vir Biotechnology MultiPlan Sionna Therapeutics Gyre Therapeutics Owens & Minor CeriBell Nutex Health Global Cord Blood (NYSE:CORBF) and Global Cord Blood (NYSE:CO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk. Which has higher valuation and earnings, CORBF or CO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobal Cord Blood$196.12M0.34$79.04MN/AN/AGlobal Cord Blood$1.24B0.14$79.04M$0.642.27 Which has more risk and volatility, CORBF or CO? Global Cord Blood has a beta of -0.52, meaning that its stock price is 152% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500. Is CORBF or CO more profitable? Company Net Margins Return on Equity Return on Assets Global Cord BloodN/A N/A N/A Global Cord Blood N/A N/A N/A Does the media prefer CORBF or CO? In the previous week, Global Cord Blood and Global Cord Blood both had 1 articles in the media. Global Cord Blood's average media sentiment score of 0.56 beat Global Cord Blood's score of 0.00 indicating that Global Cord Blood is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Global Cord Blood 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Global Cord Blood 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGlobal Cord Blood beats Global Cord Blood on 3 of the 4 factors compared between the two stocks. Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CO vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$176.25M$87.78M$5.47B$20.52BDividend YieldN/AN/A5.25%3.76%P/E Ratio2.271.1326.9727.79Price / Sales0.140.35435.7540.48Price / Cash4.192.8036.8222.26Price / Book0.230.237.984.58Net Income$79.04M$43.11M$3.16B$982.91M7 Day Performance-3.33%-24.77%3.69%1.31%1 Month Performance22.36%-13.83%2.91%4.85%1 Year Performance31.82%20.29%34.30%14.09% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COGlobal Cord BloodN/A$1.45flatN/AN/A$176.25M$1.24B2.271,202CORBFGlobal Cord BloodN/A$1.50flatN/A-50.0%$182.33M$196.12M0.001,200MRAIMarpaiN/A$1.35-6.9%N/A+62.8%$22.32M$34.87M-0.51150Gap DownREPLReplimune Group4.1677 of 5 stars$9.29-0.4%$20.83+124.3%+19.0%$719.22MN/A-3.03210VIRVir Biotechnology3.1818 of 5 stars$5.04-2.5%$32.86+551.9%-38.2%$714.69M$74.21M-1.19580News CoverageMPLNMultiPlan0.1821 of 5 stars$43.58+1.9%$26.25-39.8%N/A$704.73M$930.62M-0.46170News CoverageHigh Trading VolumeSIONSionna TherapeuticsN/A$17.35+9.5%$38.50+121.9%N/A$698.92MN/A0.0035Positive NewsGYREGyre Therapeutics0.0859 of 5 stars$7.35-0.9%N/A-38.7%$695.68M$105.76M367.6840OMIOwens & Minor4.8489 of 5 stars$9.10+2.6%$11.60+27.5%-31.0%$685.25M$10.70B-1.9223,200CBLLCeriBell2.7855 of 5 stars$18.73-0.9%$32.14+71.6%N/A$683.10M$65.44M0.00N/ANews CoverageNUTXNutex Health3.1923 of 5 stars$124.49+1.3%$262.50+110.9%+2,404.6%$682.72M$479.95M10.471,150News CoverageHigh Trading Volume Related Companies and Tools Related Companies CORBF Competitors MRAI Competitors REPL Competitors VIR Competitors MPLN Competitors SION Competitors GYRE Competitors OMI Competitors CBLL Competitors NUTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CO) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredElon brings 'disruption and chaos ' to DCWhat it's really like to work with Elon... "A business partner of mine has close ties to the Department of ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CO Stock Alerts